journal article·2024-01Open access

A Novel Bioswitchable miRNA Mimic Delivery System: Therapeutic Strategies Upgraded from Tetrahedral Framework Nucleic Acid System for Fibrotic Disease Treatment and Pyroptosis Pathway Inhibition

Yueying Jiang, Songhang Li, Ruijianghan Shi, Wumeng Yin, Weitong Lv, Taoran Tian, Yunfeng Lin

Advanced Science· Volume 11· Issue 1

Abstract

Abstract There has been considerable interest in gene vectors and their role in regulating cellular activities and treating diseases since the advent of nucleic acid drugs. MicroRNA (miR) therapeutic strategies are research hotspots as they regulate gene expression post‐transcriptionally and treat a range of diseases. An original tetrahedral framework nucleic acid (tFNA) analog, a bioswitchable miR inhibitor delivery system (BiRDS) carrying miR inhibitors, is previously established; however, it remains unknown whether BiRDS can be equipped with miR mimics. Taking advantage of the transport capacity of tetrahedral framework nucleic acid (tFNA) and upgrading it further, the treatment outcomes of a traditional tFNA and BiRDS at different concentrations on TGF‐β‐ and bleomycin‐induced fibrosis simultaneously in vitro and in vivo are compared. An upgraded traditional tFNA is designed by successfully synthesizing a novel BiRDS, carrying a miR mimic, miR‐27a, for treating skin fibrosis and inhibiting the pyroptosis pathway, which exhibits stability and biocompatibility. BiRDS has three times higher efficiency in delivering miRNAs than the conventional tFNA with sticky ends. Moreover, BiRDS is more potent against fibrosis and pyroptosis‐related diseases than tFNAs. These findings indicate that the BiRDS can be applied as a drug delivery system for disease treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oral Diseases National Center for Stomatology National Clinical Research Center for Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan 610041 China

Sichuan Provincial Engineering Research Center of Oral Biomaterials Sichuan University Chengdu Sichuan 610041 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Sichuan Province Youth Science and Technology Innovation Team

References (51)

Show source-provided references
1. 10.1039/D0NR07622H10.1039/D0NR07622H ↗
2. 10.1002/adma.20190108110.1002/adma.201901081 ↗
3. 10.1111/cpr.1308410.1111/cpr.13084 ↗
4. 10.1021/jacs.2c1273310.1021/jacs.2c12733 ↗
5. 10.1038/s41596-022-00791-710.1038/s41596-022-00791-7 ↗
6. 10.1002/advs.20220205810.1002/advs.202202058 ↗
7. 10.1021/acsami.1c1486110.1021/acsami.1c14861 ↗
8. 10.1016/j.bioactmat.2021.06.00310.1016/j.bioactmat.2021.06.003 ↗
9. 10.1038/nrg229010.1038/nrg2290 ↗
10. 10.1111/cpr.1327210.1111/cpr.13272 ↗
11. 10.1038/s41580-018-0045-710.1038/s41580-018-0045-7 ↗
12. 10.1186/s40425-019-0670-510.1186/s40425-019-0670-5 ↗
13. 10.1016/j.tig.2022.02.00610.1016/j.tig.2022.02.006 ↗
14. 10.2174/157016111366615040110160310.2174/1570161113666150401101603 ↗
15. 10.3390/ijms23191150210.3390/ijms231911502 ↗
16. 10.1038/nrd.2016.24610.1038/nrd.2016.246 ↗
17. 10.1111/cpr.1310510.1111/cpr.13105 ↗
18. 10.1111/cpr.1320610.1111/cpr.13206 ↗
19. 10.1016/j.apmt.2020.10072510.1016/j.apmt.2020.100725 ↗
20. 10.1021/acsami.1c2370810.1021/acsami.1c23708 ↗
21. 10.1021/acsami.2c0287710.1021/acsami.2c02877 ↗
22. 10.1021/acsami.0c1380610.1021/acsami.0c13806 ↗
23. 10.1002/adfm.20210414110.1002/adfm.202104141 ↗
24. 10.1002/adma.20220428710.1002/adma.202204287 ↗
25. 10.1038/s41586-020-2938-910.1038/s41586-020-2938-9 ↗
26. 10.1111/cpr.1327910.1111/cpr.13279 ↗
27. 10.1039/D3MH00411B10.1039/D3MH00411B ↗
28. 10.3390/cells1012350910.3390/cells10123509 ↗
29. 10.1038/s41392-021-00507-510.1038/s41392-021-00507-5 ↗
30. 10.1016/j.ygeno.2022.11039110.1016/j.ygeno.2022.110391 ↗
31. 10.1111/jcmm.1581410.1111/jcmm.15814 ↗
32. 10.1186/s12974-020-02040-810.1186/s12974-020-02040-8 ↗
33. 10.1038/s41368-022-00171-710.1038/s41368-022-00171-7 ↗
34. 10.1126/science.aar297110.1126/science.aar2971 ↗
35. 10.1038/s41467-022-32855-310.1038/s41467-022-32855-3 ↗
36. 10.1186/s12943-022-01569-x10.1186/s12943-022-01569-x ↗
37. 10.3390/jcm1119556710.3390/jcm11195567 ↗
38. 10.1038/s41598-021-81735-110.1038/s41598-021-81735-1 ↗
39. 10.1172/JCI2428210.1172/JCI24282 ↗
40. 10.1016/j.cbi.2018.07.00810.1016/j.cbi.2018.07.008 ↗
41. 10.1038/nature0703910.1038/nature07039 ↗
42. 10.3390/antiox1205105210.3390/antiox12051052 ↗
43. 10.2174/138920371766615120119224710.2174/1389203717666151201192247 ↗
44. 10.1016/j.clindermatol.2013.05.02110.1016/j.clindermatol.2013.05.021 ↗
45. 10.1038/nrneph.2016.4810.1038/nrneph.2016.48 ↗
46. 10.1002/adma.20220251310.1002/adma.202202513 ↗
47. 10.1186/s13075-023-03136-110.1186/s13075-023-03136-1 ↗
48. 10.1186/s13054-021-03775-310.1186/s13054-021-03775-3 ↗
49. 10.1007/s10495-022-01729-w10.1007/s10495-022-01729-w ↗
50. 10.1038/s41419-021-04143-310.1038/s41419-021-04143-3 ↗
51. 10.1186/s13075-015-0659-510.1186/s13075-015-0659-5 ↗